Tharimmune Statistics

Total Valuation

Tharimmune has a market cap or net worth of $2.95 million. The enterprise value is $2.15 million.

Market Cap	2.95M
Enterprise Value	2.15M

Important Dates

The last earnings date was Monday, May 12, 2025, before market open.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Tharimmune has 2.11 million shares outstanding. The number of shares has increased by 471.11% in one year.

Current Share Class	2.11M
Shares Outstanding	2.11M
Shares Change (YoY)	+471.11%
Shares Change (QoQ)	+44.09%
Owned by Insiders (%)	0.67%
Owned by Institutions (%)	6.41%
Float	2.09M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	-3.62
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.67

Current Ratio	0.67
Quick Ratio	0.43
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-723.76

Financial Efficiency

Return on equity (ROE) is -400.44% and return on invested capital (ROIC) is -242.71%.

Return on Equity (ROE)	-400.44%
Return on Assets (ROA)	-149.70%
Return on Invested Capital (ROIC)	-242.71%
Return on Capital Employed (ROCE)	1,550.71%
Revenue Per Employee	n/a
Profits Per Employee	-$4.16M
Employee Count	3
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -74.84% in the last 52 weeks. The beta is 1.14, so Tharimmune's price volatility has been higher than the market average.

Beta (5Y)	1.14
52-Week Price Change	-74.84%
50-Day Moving Average	1.37
200-Day Moving Average	2.11
Relative Strength Index (RSI)	48.94
Average Volume (20 Days)	200,315

Short Selling Information

The latest short interest is 115,417, so 5.47% of the outstanding shares have been sold short.

Short Interest	115,417
Short Previous Month	73,528
Short % of Shares Out	5.47%
Short % of Float	5.51%
Short Ratio (days to cover)	0.54

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-12.63M
Pretax Income	-8.88M
Net Income	-12.48M
EBITDA	n/a
EBIT	-12.63M
Earnings Per Share (EPS)	-$7.27

Full Income Statement

Balance Sheet

The company has $1.08 million in cash and $271,454 in debt, giving a net cash position of $804,474 or $0.38 per share.

Cash & Cash Equivalents	1.08M
Total Debt	271,454
Net Cash	804,474
Net Cash Per Share	$0.38
Equity (Book Value)	-814,671
Book Value Per Share	-0.39
Working Capital	-814,671

Full Balance Sheet

Cash Flow

Operating Cash Flow	-10.77M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Tharimmune does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-471.11%
Shareholder Yield	-471.11%
Earnings Yield	-422.83%
FCF Yield	n/a

Analyst Forecast

The average price target for Tharimmune is $17.00, which is 1,114.29% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$17.00
Price Target Difference	1,114.29%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on May 28, 2024. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	May 28, 2024
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1